Testing effectiveness (Phase 2)Study completedNCT04399577
What this trial is testing
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
Who this might be right for
Warts
Zagazig University 39